Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy

Completed · Not applicable

Conditions studied: Cancer of the Cervix, Cancer of the Endometrium

In brief

This is an observational study. The purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter (nanoFOD) for the real time dosimetric monitoring of brachytherapy treatment. Women with gynecologic cancers treated with brachytherapy as part of their standard therapeutic regimen will represent the study population.

Key facts

Study ID

NCT02040155

Run by

Duke University

People needed

16

Starts

2014-02-01

Expected to finish

2015-08-01

Last updated by the study team

2017-05-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Histologically documented neoplasm of the female genital tract.
• Planned brachytherapy as part of standard of care treatment.
• Age > 18 years
• Able to provide and execute informed consent

You may not qualify if…

• Any clinical scenario in which the nanoFOD placement or reading would compromise the treatment efficacy, or endanger the patient in any way.

Where it is running

• Duke Cancer Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.